WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Funds will be used to create a support network for providers of HIV/AIDS care Holy Cross Health has received a three-year grant from ViiV Positive Action Network to develop a support network for peers ...

The story of the AIDS movement is one of regular people: students, bartenders, stay-at-home mothers, teachers, retired lawyers, immigrants, Catholic nuns, newly out gay men who had just arrived in New ...

There is still no cure or effective vaccine for HIV, but scientists have opened up new possibilities in HIV treatment and ...

To be or not to be? Daily oral versus long-acting injectable medicines for HIV prevention BY SHOBHA SHUKLA – CNS To be or not to be? Daily oral versus long-acting injectable medicines for HIV ...

Some had lost friends or lovers. Some felt a moral calling. Some were just trying to balance their sexual karma. Many were angry. Most had no medical background or professional credentials – just a ...

Dr Oluga said nearly 6,000 new HIV infections were recorded among individuals aged 15 to 24 which is troubling.